Shigehumi Yoshino

Relation between cytokine promoter gene polymorphism and toxicity of 5-fluorouracil plus cisplatin chemotherapy

Kazuhiko Sakamoto, Masaaki Oka, Shigehumi Yoshino et al. · Oncology Reports · 2006 · 24 citations · Full text

Medicine, Genetics, Oncology +14

Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: Results of a randomized study on host quality of life and immune function improvement

Yukiko Nagashima, Shigehumi Yoshino, Shigeru Yamamoto et al. · Molecular and Clinical Oncology · 2017 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16

Relationship Between Cytokine Gene Polymorphisms and Risk of Postoperative Pneumonia with Esophageal Cancer

Kazuhiko Sakamoto, Masaaki Oka, Shigehumi Yoshino et al. · Journal of Gastrointestinal Surgery · 2014 · 12 citations · Full text

Life Sciences, Genetics, Oncology +17

[Evaluation of host immunity and side effects in breast cancer patients treated with adjuvant chemotherapy (FEC therapy)].

Yukiko Nagashima, Noriko Sanpei, Shigeru Yamamoto et al. · PubMed · 2005 · 12 citations

Medicine, Immunology, Oncology +13